Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Creasy

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
American Journal of Obstetrics and Gynecology|February 1, 1994
The effect of the oxytocin antagonist atosiban on preterm uterine activity in the humanT M Goodwin, R Paul, H Silver, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|July 23, 2016
Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM studyR Romero, K H Nicolaides, A Conde-Agudelo, et al.
Contraception|September 27, 2015
Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiolD F Archer, M A Thomas, J Conard, et al.
American Journal of Obstetrics and Gynecology|May 20, 2000
Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study GroupG J Valenzuela, L Sanchez-Ramos, R Romero, et al.
American Journal of Obstetrics and Gynecology|May 20, 2000
An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescueR Romero, B M Sibai, L Sanchez-Ramos, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 28, 2007
Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trialJ M O'Brien, C D Adair, D F Lewis, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|April 8, 2011
Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trialS S Hassan, R Romero, D Vidyadhari, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 28, 2007
Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trialE A DeFranco, J M O'Brien, C D Adair, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
American Journal of Obstetrics and Gynecology|February 1, 1994
The effect of the oxytocin antagonist atosiban on preterm uterine activity in the humanT M Goodwin, R Paul, H Silver, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|July 23, 2016
Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM studyR Romero, K H Nicolaides, A Conde-Agudelo, et al.
Contraception|September 27, 2015
Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiolD F Archer, M A Thomas, J Conard, et al.
American Journal of Obstetrics and Gynecology|May 20, 2000
Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study GroupG J Valenzuela, L Sanchez-Ramos, R Romero, et al.
American Journal of Obstetrics and Gynecology|May 20, 2000
An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescueR Romero, B M Sibai, L Sanchez-Ramos, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 28, 2007
Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trialJ M O'Brien, C D Adair, D F Lewis, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|April 8, 2011
Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trialS S Hassan, R Romero, D Vidyadhari, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 28, 2007
Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trialE A DeFranco, J M O'Brien, C D Adair, et al.
Pageof 3